BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21807296)

  • 1. Personalized therapy for non-small cell lung cancer: hype or clinical reality?
    Wigle DA
    Semin Thorac Cardiovasc Surg; 2011; 23(1):30-5. PubMed ID: 21807296
    [No Abstract]   [Full Text] [Related]  

  • 2. The tissue is the issue: personalized medicine for non-small cell lung cancer.
    Hirsch FR; Wynes MW; Gandara DR; Bunn PA
    Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine for non-small-cell lung cancer.
    Mok TS; Zhou Q; Leung L; Loong HH
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1601-11. PubMed ID: 20942631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The coming of age of molecular tumor profiling.
    Antonoff MB; D'Cunha J
    Semin Thorac Cardiovasc Surg; 2011; 23(1):8-9. PubMed ID: 21807290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Personalizing" therapy for non-small cell lung cancer.
    D'Cunha J
    Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancer.
    Rothschild SI; Gautschi O; Lara PN; Mack PC; Gandara DR
    Curr Opin Oncol; 2011 Mar; 23(2):150-7. PubMed ID: 21119513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer.
    Kulesza P; Ramchandran K; Patel JD
    Am J Clin Pathol; 2011 Aug; 136(2):228-38. PubMed ID: 21757595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic medicine in non-small cell lung cancer: paving the path to personalized care.
    Sriram KB; Larsen JE; Yang IA; Bowman RV; Fong KM
    Respirology; 2011 Feb; 16(2):257-63. PubMed ID: 21044232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personalized, targeted treatment of non-small cell lung cancer].
    Wolf J
    Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular prognostication of non-small cell lung cancer.
    Tsao MS; Jablons DM
    Semin Thorac Cardiovasc Surg; 2013; 25(1):4-7. PubMed ID: 23800523
    [No Abstract]   [Full Text] [Related]  

  • 11. Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
    Buikhuisen WA; Burgers JA; Vincent AD; Schellens JH; Beijnen JH; Smit EF; Joerger M
    J Clin Oncol; 2010 Sep; 28(27):e482-3; author reply e484. PubMed ID: 20606096
    [No Abstract]   [Full Text] [Related]  

  • 12. Advancing personalized cancer medicine in lung cancer.
    MacConaill LE
    Arch Pathol Lab Med; 2012 Oct; 136(10):1210-6. PubMed ID: 23020726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer - genomics and personalized medicine.
    Mahapatra A
    ACS Chem Biol; 2010 Jun; 5(6):529-31. PubMed ID: 20557136
    [No Abstract]   [Full Text] [Related]  

  • 15. Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progress.
    Gridelli C
    Curr Opin Oncol; 2012 Mar; 24(2):115-6. PubMed ID: 22123236
    [No Abstract]   [Full Text] [Related]  

  • 16. Personalized medicine: Lung Cancer leads the way.
    Parikh P; Puri T
    Indian J Cancer; 2013; 50(2):77-9. PubMed ID: 23979195
    [No Abstract]   [Full Text] [Related]  

  • 17. The future of oncology treatment through diagnostic testing.
    Oakley G
    MLO Med Lab Obs; 2013 Dec; 45(12):38. PubMed ID: 24409595
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
    Simon G; Sharma A; Li X; Hazelton T; Walsh F; Williams C; Chiappori A; Haura E; Tanvetyanon T; Antonia S; Cantor A; Bepler G
    J Clin Oncol; 2007 Jul; 25(19):2741-6. PubMed ID: 17602079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smokers have 10 times more genetic damage in lung cancer tumors.
    Cancer; 2013 Jan; 119(2):248-9. PubMed ID: 23292898
    [No Abstract]   [Full Text] [Related]  

  • 20. Five-gene signature in non-small-cell lung cancer.
    Quintás-Cardama A; Gibbons DL
    N Engl J Med; 2007 Apr; 356(15):1582-3; author reply 1583. PubMed ID: 17436429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.